» Articles » PMID: 38005886

Seneca Valley Virus Degrades STING Via PERK and ATF6-Mediated Reticulophagy

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Nov 25
PMID 38005886
Authors
Affiliations
Soon will be listed here.
Abstract

Seneca Valley Virus (SVV), a member of the family, is an emerging porcine virus that can cause vesicular disease in pigs. However, the immune evasion mechanism of SVV remains unclear, as does its interaction with other pathways. STING (Stimulator of interferon genes) is typically recognized as a critical factor in innate immune responses to DNA virus infection, but its role during SVV infection remains poorly understood. In the present study, we observed that STING was degraded in SVV-infected PK-15 cells, and SVV replication in the cells was affected when STING was knockdown or overexpressed. The STING degradation observed was blocked when the SVV-induced autophagy was inhibited by using autophagy inhibitors (Chloroquine, Bafilomycin A1) or knockdown of autophagy related gene 5 (ATG5), suggesting that SVV-induced autophagy is responsible for STING degradation. Furthermore, the STING degradation was inhibited when reticulophagy regulator 1 (FAM134B), a reticulophagy related receptor, was knocked down, indicating that SVV infection induces STING degradation via reticulophagy. Further study showed that in eukaryotic translation initiation factor 2 alpha kinase 3 (PERK)/activating transcription factor 6 (ATF6) deficient cells, SVV infection failed to induce reticulophagy-medaited STING degradation, indicating that SVV infection caused STING degradation via PERK/ATF6-mediated reticulophagy. Notably, blocking reticulophagy effectively hindered SVV replication. Overall, our study suggested that SVV infection resulted in STING degradation via PERK and ATF6-mediated reticulophagy, which may be an immune escape strategy of SVV. This finding improves the understanding of the intricate interplay between viruses and their hosts and provides a novel strategy for the development of novel antiviral drugs.

Citing Articles

The cGAS-STING/PERK-eIF2α: Individual or Potentially Collaborative Signaling Transduction in Cardiovascular Diseases.

Wan X, Zhang H, Tian J, Liu L, An Z, Zhao X Int J Biol Sci. 2024; 20(15):5868-5887.

PMID: 39664570 PMC: 11628330. DOI: 10.7150/ijbs.101247.


Reticulophagy and viral infection.

Wilson A, McCormick C Autophagy. 2024; 21(1):3-20.

PMID: 39394962 PMC: 11702952. DOI: 10.1080/15548627.2024.2414424.


Endoplasmic reticulum stress in diseases.

Liu Y, Xu C, Gu R, Han R, Li Z, Xu X MedComm (2020). 2024; 5(9):e701.

PMID: 39188936 PMC: 11345536. DOI: 10.1002/mco2.701.

References
1.
Wan D, Jiang W, Hao J . Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response. Front Immunol. 2020; 11:615. PMC: 7198750. DOI: 10.3389/fimmu.2020.00615. View

2.
Neufeldt C, Cerikan B, Cortese M, Frankish J, Lee J, Plociennikowska A . SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB. Commun Biol. 2022; 5(1):45. PMC: 8755718. DOI: 10.1038/s42003-021-02983-5. View

3.
Jiang S, Xia N, Luo J, Zhang Y, Cao Q, Zhang J . The Porcine Cyclic GMP-AMP Synthase-STING Pathway Exerts an Unusual Antiviral Function Independent of Interferon and Autophagy. J Virol. 2022; 96(23):e0147622. PMC: 9749457. DOI: 10.1128/jvi.01476-22. View

4.
Tian M, Liu W, Zhang Q, Huang Y, Li W, Wang W . MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway. Cell Rep. 2020; 33(3):108297. DOI: 10.1016/j.celrep.2020.108297. View

5.
Li Y, He M, Wang Z, Duan Z, Guo Z, Wang Z . STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis. Cell Mol Immunol. 2021; 19(1):92-107. PMC: 8752589. DOI: 10.1038/s41423-021-00801-w. View